dexamethasone 21-phosphate has been researched along with Cochlear Hearing Loss in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Do, BH; Kawaguchi, R; Kitamura, T; Ohbuchi, T; Suzuki, H; Wakasugi, T | 1 |
| Dellamary, L; Fernandez, R; Harrop-Jones, A; LeBel, C; Piu, F; Wang, X | 1 |
| Kawasaki, T; Ogawa, K; Suzuki, N; Tomisato, S; Wasano, K; Yamamoto, S | 1 |
3 other study(ies) available for dexamethasone 21-phosphate and Cochlear Hearing Loss
| Article | Year |
|---|---|
Efficacy of Intratympanic Steroid on Idiopathic Sudden Sensorineural Hearing Loss: An Analysis of Cases With Negative Prognostic Factors.
Topics: Anti-Inflammatory Agents; Audiometry; Dexamethasone; Female; Glucocorticoids; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Hydrocortisone; Hyperbaric Oxygenation; Injection, Intratympanic; Male; Middle Aged; Middle Ear Ventilation; Prednisolone; Prognosis; Recovery of Function; Retrospective Studies; Time-to-Treatment; Treatment Outcome; Vertigo | 2019 |
The Sustained-Exposure Dexamethasone Formulation OTO-104 Offers Effective Protection against Cisplatin-Induced Hearing Loss.
Topics: Animals; Antineoplastic Agents; Cisplatin; Dexamethasone; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Female; Glucocorticoids; Guinea Pigs; Hearing; Hearing Loss, Sensorineural; Hydrogel, Polyethylene Glycol Dimethacrylate; Injection, Intratympanic; Poloxamer | 2016 |
Successful continual intratympanic steroid injection therapy in a patient with refractory sensorineural hearing loss accompanied by relapsing polychondritis.
Topics: Audiometry, Pure-Tone; Dexamethasone; Female; Glucocorticoids; Hearing Loss, Sensorineural; Hearing Loss, Unilateral; Humans; Injection, Intratympanic; Middle Aged; Polychondritis, Relapsing; Treatment Outcome | 2017 |